What is the range of mutational rearrangements and alterations that can be identified by hybrid capture-based NGS and that have clinical applications?

What is the range of mutational rearrangements and alterations that can be identified by hybrid capture-based NGS and that have clinical applications?

What is the range of mutational rearrangements and alterations that can be identified by hybrid capture-based NGS and that have clinical applications?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Lynn Wang, MD, PhD, FCAP

Professor Lynn Wang, MD, PhD, FCAP

Professor, Division of Genomic and Molecular Pathology
Founding Medical Director
Genomic and Molecular Pathology
University of Chicago Medical Center
Chicago, IL, USA